Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

[A study of in vitro activity of daptomycin against 2679 Gram-positive cocci].

Zhang FF, Zhao CJ, Wang ZW, Liu WY, Yan W, Peng QS, Jiang S, Guo Y, Liu JB, Chen HB, Li HN, Wang Q, Wang H.

Zhonghua Nei Ke Za Zhi. 2013 Jun;52(6):474-9. Chinese.

PMID:
24059993
2.

[In vitro activity of daptomycin and other antimicrobial agents against 499 strains of gram-positive cocci causing bloodstream infection].

Yang QW, Wang H, Sun HL, Xu YC, Xie XL, Chen MJ.

Zhonghua Nei Ke Za Zhi. 2009 Mar;48(3):220-4. Chinese.

PMID:
19576091
3.

In vitro activity of daptomycin against Gram-positive cocci: the first multicentre study in Greece.

Malli E, Spiliopoulou I, Kolonitsiou F, Klapsa D, Giannitsioti E, Pantelidi K, Pratti A, Panopoulou M, Grapsa S, Alepopoulou E, Neonakis I, Frantzidou F, Alexiou-Daniel S, Bakola D, Koutsia-Carouzou C, Malamou-Lada H, Zerva L, Vlahaki E, Kartali-Ktenidou S, Anastassiou ED, Petinaki E.

Int J Antimicrob Agents. 2008 Dec;32(6):525-8. doi: 10.1016/j.ijantimicag.2008.05.020. Epub 2008 Sep 5.

PMID:
18774268
4.
5.
6.

Antimicrobial resistance trends among 5608 clinical Gram-positive isolates in China: results from the Gram-Positive Cocci Resistance Surveillance program (2005-2010).

Zhao C, Sun H, Wang H, Liu Y, Hu B, Yu Y, Sun Z, Chu Y, Cao B, Liao K, Lei J, Hu Z, Zhang L, Zhang X, Xu Y, Wang Z, Chen M.

Diagn Microbiol Infect Dis. 2012 Jun;73(2):174-81. doi: 10.1016/j.diagmicrobio.2012.03.003. Epub 2012 Apr 21.

PMID:
22521693
7.

[An antimicrobial resistance surveillance of gram-positive cocci isolated from 12 teaching hospitals in China in 2009].

Sun HL, Wang H, Chen MJ, Liu YM, Hu ZD, Liao K, Chu YZ, Lei JE, Zhang B, Yu YS, Hu BJ, Sun ZY, Zhang Z, He QY.

Zhonghua Nei Ke Za Zhi. 2010 Sep;49(9):735-40. Chinese.

PMID:
21092441
8.

Daptomycin susceptibility of 833 strains of Gram-positive cocci from a university hospital in Japan (2009-2011).

Yoshizumi A, Ishii Y, Iwata M, Murakami H, Yumoto S, Yasui K, Maehara C, Fukuzawa S, Enokizono K, Tateda K.

Diagn Microbiol Infect Dis. 2014 Oct;80(2):151-3. doi: 10.1016/j.diagmicrobio.2014.06.011. Epub 2014 Jun 21.

PMID:
25056827
9.
10.

Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011.

Sader HS, Flamm RK, Jones RN.

Antimicrob Agents Chemother. 2013 Jul;57(7):3178-81. doi: 10.1128/AAC.00484-13. Epub 2013 Apr 29.

11.

Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006.

Zhanel GG, DeCorby M, Nichol KA, Wierzbowski A, Baudry PJ, Karlowsky JA, Lagacé-Wiens P, Walkty A, Mulvey MR, Hoban DJ; Canadian Antimicrobial Resistance Alliance.

Diagn Microbiol Infect Dis. 2008 Sep;62(1):67-80. doi: 10.1016/j.diagmicrobio.2008.04.012. Epub 2008 May 29.

PMID:
18513913
12.

[In vitro activity of daptomycin against VRE and MRSA strains].

Aktaş G, Derbentli S.

Mikrobiyol Bul. 2014 Jan;48(1):123-8. Turkish.

13.

In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC.

Kao TM, Wang JT, Weng CM, Chen YC, Chang SC.

J Microbiol Immunol Infect. 2011 Oct;44(5):346-51. doi: 10.1016/j.jmii.2011.01.037. Epub 2011 Jan 20.

14.

Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005).

Pfaller MA, Sader HS, Jones RN.

Diagn Microbiol Infect Dis. 2007 Apr;57(4):459-65. Epub 2007 Jan 19.

PMID:
17240105
16.

Susceptibility of gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid. The Linezolid Study Group.

Henwood CJ, Livermore DM, Johnson AP, James D, Warner M, Gardiner A.

J Antimicrob Chemother. 2000 Dec;46(6):931-40.

17.

Activity of linezolid against Gram-positive cocci isolated in French hospitals as determined by three in-vitro susceptibility testing methods.

Muller-Serieys C, Drugeon HB, Etienne J, Lascols C, Leclercq R, Nguyen J, Soussy CJ.

Clin Microbiol Infect. 2004 Mar;10(3):242-6.

18.

Antimicrobial susceptibility of gram-positive bacteria isolated in Brazilian hospitals participating in the SENTRY Program (2005-2008).

Gales AC, Sader HS, Ribeiro J, Zoccoli C, Barth A, Pignatari AC.

Braz J Infect Dis. 2009 Apr;13(2):90-8.

19.

Update of the in vitro activity of daptomycin tested against 6710 Gram-positive cocci isolated in North America (2006).

Castanheira M, Jones RN, Sader HS.

Diagn Microbiol Infect Dis. 2008 Jun;61(2):235-9. doi: 10.1016/j.diagmicrobio.2008.01.016. Epub 2008 Mar 7.

PMID:
18314293
20.

Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of Gram-positive cocci.

Tsao SM, Lin HC, Lee CM, Hsu GJ, Chen CM, Sun W, Liu YC, Jang TN, Cheng YJ, Lu PL, Chiang PC, Wang LS, Kung HC, Chuang YC, Shi ZY, Liu JW, Huang CH, Lu CT, Liao CH, Hsueh PR.

Int J Antimicrob Agents. 2008 Nov;32 Suppl 3:S184-7. doi: 10.1016/S0924-8579(08)70025-6. Erratum in: Int J Antimicrob Agents. 2009 Dec;34(6):617.

PMID:
19013352
Items per page

Supplemental Content

Write to the Help Desk